Springworks TherapeuticsSWTX
13F holders, Q3 2025 (September 30)3holders −220
0new positions
217sold out
$53.89avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Springworks Therapeutics Inc. (SWTX) in their 13F filings, down 220 from Q2 2025. 0 opened new positions and 217 sold out. The largest holders were DekaBank Deutsche Girozentrale ($2.2M), Osaic Holdings, Inc. ($4K) and Huntington National Bank ($47).
- Company
- Springworks Therapeutics Inc.
- CUSIP
- 85205L107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 217 | $3.6B |
All 13F filers, Q2 2025 → Q3 2025: 75,781,753 shares sold, net −75,781,753 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| DekaBank Deutsche Girozentrale | 0.00% | No change | 40,000 | $2.2M |
| Osaic Holdings, Inc. | 0.00% | Reduce -96.3% | 83 | $4K |
| Huntington National Bank | 0.00% | Reduce -99.8% | 1 | $47 |
"% of holder's portfolio" is SWTX's weight in each manager's 13F, not the share of Springworks Therapeutics Inc. the manager owns.